Meridian Wealth Partners’s Exelixis EXEL Stock Holding History

Meridian Wealth Partners’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-59	Closed	-$1K	–	477
2021 Q1	$1K	Buy	+59	New	+$1.33K	﹤0.01%	1155

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Meridian Wealth Partners's EXEL Position: Q2 2021 in Review

Meridian Wealth Partners sold out of Exelixis (EXEL) in Q2 2021, closing a stake of 59 shares — an estimated $1K sold.

Meridian Wealth Partners first reported a position in EXEL in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 344 funds tracked by Wall St. Rank hold EXEL as of Q2 2021.

Meridian Wealth Partners reported no remaining Exelixis position as of Q2 2021 after selling out during the quarter.
Meridian Wealth Partners sold 59 Exelixis shares in Q2 2021, an estimated $1K.
Meridian Wealth Partners first reported a position in Exelixis in Q1 2021 and held it in 1 quarter.
Meridian Wealth Partners's Exelixis position peaked at $1K in Q1 2021.
344 funds tracked by Wall St. Rank held Exelixis as of Q2 2021.

Based on Meridian Wealth Partners's 13F filing for Q2 2021, filed 12 Aug 2021.